Brief: Mithra Completes Recruitment Of COVID-19 Phase II Study

Mithra Pharmaceuticals SA

17/06/2021 06:39

June 17 (Reuters) - MITHRA PHARMACEUTICALS SA  MITRA.BR :
    * MITHRA COMPLETES RECRUITMENT OF COVID-19 PHASE II STUDY
    * INTERNATIONAL EXPERT PANEL CONFIRMS STRONG SCIENTIFIC
BASIS FOR
ESTROGENS AS POTENTIAL TREATMENT OF COVID-19 AND OTHER VIRAL
DISEASES
    * COMPLETION OF RECRUITMENT OF MALE AND FEMALE PATIENTS
SUFFERING
FROM COVID-19 INFECTION FOR PHASE II CORONESTA PROGRAM
    * FIRST PROSPECTIVE CLINICAL TRIAL OF AN ESTROGEN EXPECTED
TO
REPORT RESULTS IN COVID-19
    * POSITIVE DSMB1 ASSESSMENT FROM A SAFETY PERSPECTIVE,
ALLOWING
TRIAL TO PROCEED: TOP-LINE DATA EXPECTED SUMMER 2021

Source text for Eikon:  ID:nNDL3V2kMB 
Further company coverage:  MITRA.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))